Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
[Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.
Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
Multiple Sclerosis.
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury.
Chronic inflammatory demyelinating polyneuropathy in common variable immunodeficiency.
Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Disability profile of multiple sclerosis in New Zealand.
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Role of executive functions in prospective memory in multiple sclerosis: Impact of the strength of cue-action association.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Deletion of jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.

Pages